Right Heart Failure
33
7
9
12
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.1%
2 terminated out of 33 trials
85.7%
-0.8% vs benchmark
3%
1 trials in Phase 3/4
8%
1 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (33)
Repurposing Valsartan May Protect Against Pulmonary Hypertension
Accelerated LBBP for Patients With RHF and Severe TR
Incidence and Evolution of Heart-lung Interaction in Acute Respiratory Distress Syndrome
Open Lung Strategy, Gas Distribution and Right Heart Function in ARDS Patients
Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation
Effect of APRV vs. LTV on Right Heart Function in ARDS Patients: a Single-center Randomized Controlled Study
Feasibility Trial for a Right Ventricular Failure Platform Trial
Cholate Clearance in Fontan and Heart Failure
Clinical Characteristics and Outcomes of Patients With Pulmonary Hypertension Associated Right Heart Failure
Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension
Definition and Management of Right Ventricular Injury in Adult Patients Receiving Extracorporeal Membrane Oxygenation
Right Ventricular Pressure Waveform Monitoring in Cardiac Surgery
Femoral Venous Pulsatility and Right Heart Dysfunction in Heart Surgery: An Observational Study
Repository of Phase Signals for Pulmonary Hypertension Algorithm Development
Pforzheim Tricuspid Valve Registry - Outcomes of Percutaneous Tricuspid Valve Repair
Right Ventricular Dysfunction in Chronic Heart Failure
Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricular Assist Device Implantation Study
Relationship Between Right Atrial Volume Index, Functional Capacity and Inflammatory Biomarkers in Patients With COPD.
Predictive Value of Vasodilator Challenge for Right Heart Failure After LVAD Implantation